Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Wells

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Annals of Pharmacotherapy|January 17, 2002
Olanzapine-induced diabetic ketoacidosisK R Ragucci, B J Wells
Respiratory Medicine|July 29, 2018
A comprehensive care plan that reduces readmissions after acute exacerbations of COPDJ A Ohar, C H Loh, K M Lenoir, et al.
Diabetes, Obesity & Metabolism|November 9, 2013
Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitusG E C Sun, B J Wells, K Yip, et al.
Diabetes, Obesity & Metabolism|April 11, 2012
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysisK M Pantalone, M W Kattan, C Yu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 18, 2012
The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysisK M Pantalone, M W Kattan, C Yu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Annals of Pharmacotherapy|January 17, 2002
Olanzapine-induced diabetic ketoacidosisK R Ragucci, B J Wells
Respiratory Medicine|July 29, 2018
A comprehensive care plan that reduces readmissions after acute exacerbations of COPDJ A Ohar, C H Loh, K M Lenoir, et al.
Diabetes, Obesity & Metabolism|November 9, 2013
Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitusG E C Sun, B J Wells, K Yip, et al.
Diabetes, Obesity & Metabolism|April 11, 2012
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysisK M Pantalone, M W Kattan, C Yu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 18, 2012
The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysisK M Pantalone, M W Kattan, C Yu, et al.
Pageof 1